Predictions
Zoom Video Communications Inc
Start price
Target price
Perf. (%)
€128.96
30.01.22
30.01.22
€132.00
30.01.23
30.01.23
-31.18%
14.03.22
14.03.22
Top 10 in its market
Future proof or reliable business model
negative Cash Flow expected
Significant cyclical dependencies
Zoom Video Communications Inc
Start price
Target price
Perf. (%)
€124.20
24.01.22
24.01.22
€112.00
24.01.23
24.01.23
3.83%
30.01.22
30.01.22
Top 10 in its market
Future proof or reliable business model
negative Cash Flow expected
Significant cyclical dependencies
Moderna Inc.
Start price
Target price
Perf. (%)
€137.00
23.01.22
23.01.22
-
23.01.23
23.01.23
4.37%
06.02.22
06.02.22
Could be very worthwhile Investment >20% year
Moderna Inc.
Start price
Target price
Perf. (%)
€137.00
22.01.22
22.01.22
€165.00
22.01.23
22.01.23
4.37%
06.02.22
06.02.22
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
Moderna Inc.
Start price
Target price
Perf. (%)
€139.80
21.01.22
21.01.22
€160.00
21.01.23
21.01.23
-2.00%
22.01.22
22.01.22
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
Mercury Comp. Sys
Start price
Target price
Perf. (%)
€49.20
10.01.22
10.01.22
€60.00
10.01.23
10.01.23
17.89%
21.03.22
21.03.22
Could be worthwhile Investment >10% per year
Innovative
Known brand
Novanta Inc
Start price
Target price
Perf. (%)
€141.00
10.01.22
10.01.22
€150.00
10.01.23
10.01.23
-8.51%
10.01.23
10.01.23
Could be worthwhile Investment >10% per year
Some uniques
Future proof or reliable business model
Higher risks for its business
Novocure Ltd
Start price
Target price
Perf. (%)
€59.26
09.01.22
09.01.22
€51.00
09.01.23
09.01.23
8.34%
16.03.22
16.03.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
UFP Industries Inc.
Start price
Target price
Perf. (%)
€81.50
28.12.21
28.12.21
€85.00
28.12.22
28.12.22
-8.71%
29.12.22
29.12.22
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Tandem Diabetes Care Inc
Start price
Target price
Perf. (%)
€136.00
28.12.21
28.12.21
€142.00
28.12.22
28.12.22
-70.42%
29.12.22
29.12.22
Could be worthwhile Investment >10% per year
Capable Management
Future proof or reliable business model
Opko Health Inc.
Start price
Target price
Perf. (%)
€4.65
28.12.21
28.12.21
-
28.12.22
28.12.22
-75.54%
29.12.22
29.12.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€143.65
27.12.21
27.12.21
-
27.12.22
27.12.22
-9.78%
09.01.22
09.01.22
Risky Investment
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€37.99
27.12.21
27.12.21
€42.00
27.12.22
27.12.22
-5.05%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Moderna Inc.
Start price
Target price
Perf. (%)
€224.75
25.12.21
25.12.21
€260.00
25.12.22
25.12.22
-14.41%
06.01.22
06.01.22
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
Zoom Video Communications Inc
Start price
Target price
Perf. (%)
€182.72
20.12.21
20.12.21
€162.00
20.12.22
20.12.22
-32.03%
24.01.22
24.01.22
Top 10 in its market
Future proof or reliable business model
negative Cash Flow expected
Significant cyclical dependencies
Neogen Corp.
Start price
Target price
Perf. (%)
€35.40
14.12.21
14.12.21
€38.00
14.12.22
14.12.22
-59.89%
15.12.22
15.12.22
Could be worthwhile Investment >10% per year
Arena Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€81.50
13.12.21
13.12.21
-
13.12.22
13.12.22
1.23%
06.01.22
06.01.22
Probably not worthwhile Investment
ON Semiconductor Corp
Start price
Target price
Perf. (%)
€59.06
13.12.21
13.12.21
€65.00
13.12.22
13.12.22
10.06%
14.12.22
14.12.22
Could be worthwhile Investment >10% per year
Future proof or reliable business model
High valuation
Moderna Inc.
Start price
Target price
Perf. (%)
€232.00
12.12.21
12.12.21
-
12.12.22
12.12.22
-3.13%
25.12.21
25.12.21
Could be very worthwhile Investment >20% year